Should I Buy EUDA? EUDA 2026 Analysis

Should You Buy EUDA Health Holdings Ltd (EUDA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

1.110

1 Day change

-1.77%

52 Week Range

4.500

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: trend is still bearish (SMA_200 > SMA_20 > SMA_5) and the pattern-based forward view implies downside over the next month (-7.42%).
The stock is extremely oversold (RSI_6 ~11), so a short bounce is possible, but there is no proprietary buy signal to justify chasing it today.
Intellectia Proprietary Trading Signals
- AI Stock Picker: no signal on given stock today.
- SwingMax: No signal on given stock recently.
For an impatient buyer (no scenario provided), the current setup is more consistent with “wait/avoid” than “buy now.”

Technical Analysis

Trend: Bearish; moving averages are stacked down (SMA_200 > SMA_20 > SMA_5), indicating persistent downside pressure.
Momentum: MACD histogram is negative (-0.0308) but contracting, suggesting bearish momentum may be slowing, not reversing yet.
Oversold: RSI_6 at ~11.3 is deeply oversold, increasing odds of a reflex bounce, but oversold can persist in downtrends.
Key levels:
- Support: S1 1.183, then S2 1.036 (breaks below S1 increase risk of a push toward S2).
- Resistance: Pivot 1.419, then R1 1.656 (price needs to reclaim/hold above pivot to improve the technical picture).
Price context: Post-market ~1.23 sits just above S1 (1.183), meaning downside risk is still close if support fails.

Positive Catalysts

- Extremely oversold RSI can trigger a short-term mean-reversion bounce.
- MACD negative histogram is contracting, implying selling pressure may be easing.
- No negative news headlines reported in the last week (reduced immediate headline risk).

Neutral/Negative Catalysts

- Dominant downtrend (bearish MA structure) remains intact; oversold alone is not a buy signal.
- Pattern-based outlook suggests limited upside near-term (next day/week small gains) but meaningful risk over the next month (-7.42%).
- No strong supportive positioning signals: hedge funds and insiders show neutral activity (no conviction tailwind).
- Price is close to support (S1 1.183); a breakdown could accelerate declines toward S2 1.036.

Financial Performance

Financial snapshot unavailable (data error: "list index out of range"), so latest quarter/season growth trends cannot be assessed from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data provided, so the recent trend in upgrades/downgrades and Wall Street bull/bear view cannot be evaluated from this dataset.
Congress/politician activity: No recent congress trading data available (no influential-figure catalyst identified).

Analyst Rating

Wall Street analysts forecast EUDA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EUDA is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Buy

Hold

Sell

Current: 1.130

Low

Averages

High